

RopesTalk
Ropes & Gray LLP
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Episodes
Mentioned books

Nov 14, 2022 • 13min
Digital Assets Discussion: Implications of Ooki DAO CFTC Enforcement Action
Following the first action filed by a U.S. federal regulator against a DAO and its members, asset management attorneys Melissa Bender, Jeremy Liabo and Glen Chen discuss the Ooki DAO case and its implications on the potential liability of DAO token holders, DAO legal wrappers and the CFTC’s role in regulating digital assets.

Nov 9, 2022 • 16min
Decoding Digital Health: Digital Health Dealmaking with John Vaughan, Verily Life Sciences (Part II)
The Ropes & Gray Decoding Digital Health podcast series discusses the digital health industry and related legal, business and regulatory issues. On this episode, Digital Health Initiative co-lead and IP transactions partner, Megan Baca, is joined by Verily Life Sciences Lead Product Counsel, John Vaughan, to continue their discussion on Verily’s innovative partnerships in digital health, the challenges Verily has faced as well as the rewarding solutions that Verily and its partnerships have created.

Nov 2, 2022 • 10min
R&G Tech Studio Presents: Private Equity Partner Scott Abramowitz
Welcome to the R&G Tech Studio, a Ropes & Gray podcast series highlighting the firm’s technology attorneys, their respective practice areas and how the ever-changing tech landscape impacts their clients. On this inaugural episode, private equity partner Scott Abramowitz sits down to discuss his practice and how the fintech industry has evolved with TMT co-lead Ed Black.

Oct 26, 2022 • 17min
Decoding Digital Health: Digital Health Dealmaking with John Vaughan, Verily Life Sciences (Part I)
The Ropes & Gray Decoding Digital Health podcast series discusses the digital health industry and related legal, business and regulatory issues. On this episode, Digital Health Initiative co-lead and IP transactions partner, Megan Baca, is joined by Verily Life Sciences Lead Product Counsel, John Vaughan, for a two-part discussion on digital health dealmaking. Megan and John dive into topics related to partnership strategies between biopharma and tech companies, as well as the key opportunities and challenges associated with digital health innovation deals.

Oct 20, 2022 • 12min
Credit Facilities for Registered Investment Funds
In this Ropes & Gray podcast, finance partner Alyson Gal and counsel Patricia Teixeira discuss the use of credit facilities as an important source of liquidity and leverage for registered investment funds. They explore the regulatory landscape applicable to these facilities and review some of their key terms.

Oct 18, 2022 • 16min
Recent Legal Trends in Restrictive Covenant Enforcement and What Employers Should Know
In this Ropes & Gray podcast, Doug Brayley, employment partner and head of the employment litigation practice, and Greg Demers, counsel in the employment practice, speak with Dan Murphy, an employment, executive compensation & employee benefits associate, about recent legal trends related to the enforceability of restrictive covenants, particularly non-competition agreements, and considerations for employers going forward.

Oct 13, 2022 • 22min
Non-binding Guidance: Continued Global Pressure on Drug Pricing & Reimbursement and the Next Frontiers for Effective Market Access
Following the recent publication relating to continued global pressure on drug pricing, this episode of Ropes & Gray’s podcast series Non-binding Guidance focuses on the significant changes to global business and legal environments for drug pricing brought about by the COVID-19 pandemic and the impacts on the pharmaceutical supply chain and patient access to innovative cutting-edge therapies. Hear from Ropes & Gray’s head of European life sciences practice Lincoln Tsang and health care partner Margaux Hall as they discuss the trend of rising health care drug costs in the U.S. and the UK, significant implications of the Inflation Reduction Act and similar drug pricing policy in the countries outside the U.S., the increasing role of real-world evidence in decision making, and impacts from these changes across the U.S., Europe and worldwide.

Oct 11, 2022 • 25min
ESG and the State Coffers: An Emerging Political Battleground
In this Ropes & Gray podcast, Michael Littenberg, global head of the ESG, CSR and business and human rights practice, and Josh Lichtenstein, a benefits partner and head of the ERISA fiduciary practice, speak with Reagan Haas, an ERISA and benefits associate, about the increasing activity at the state level dictating what role, if any, ESG factors should play in managing public retirement plan assets, and other related developments. Later in the episode, Chong Park, an antitrust partner, joins the conversation to discuss assertions that some states are making that managers’ ESG commitments violate antitrust laws.

Sep 13, 2022 • 15min
Fully Invested: SEC Requests
In this episode of Fully Invested, Ropes & Gray asset management attorneys Nicole Krea, Jessica Marlin, and litigation & enforcement attorney Matt McGinnis introduce listeners to the contours and typical lifecycles of SEC examinations for registered investment advisers.

Aug 9, 2022 • 11min
Fully Invested: Private Credit Funds
In this episode of Fully Invested, Ropes & Gray asset management attorneys Laurel FitzPatrick and Jessica Marlin introduce listeners to private credit funds and the different types of debt in which such funds invest. They further discuss how a credit fund’s underlying assets affect fund terms and structure.


